Precision Biosciences Stock Fundamentals
| DTIL Stock | USD 9.82 0.41 4.01% |
Precision BioSciences fundamentals help investors to digest information that contributes to Precision BioSciences' financial success or failures. It also enables traders to predict the movement of Precision Stock. The fundamental analysis module provides a way to measure Precision BioSciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Precision BioSciences stock.
At this time, Precision BioSciences' Income Tax Expense is quite stable compared to the past year. Net Interest Income is expected to rise to about 5.9 M this year, although the value of Total Revenue will most likely fall to about 35.8 M. Precision | Select Account or Indicator |
Precision BioSciences Company Operating Margin Analysis
Precision BioSciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Precision BioSciences Operating Margin | (2.12) % |
Most of Precision BioSciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precision BioSciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Precision Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Precision BioSciences has an Operating Margin of -2.1157%. This is 93.97% lower than that of the Biotechnology sector and 98.11% lower than that of the Health Care industry. The operating margin for all United States stocks is 61.6% lower than that of the firm.
Precision BioSciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Precision BioSciences's current stock value. Our valuation model uses many indicators to compare Precision BioSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Precision BioSciences competition to find correlations between indicators driving Precision BioSciences's intrinsic value. More Info.Precision BioSciences is rated below average in return on equity category among related companies. It is rated # 2 in return on asset category among related companies . At this time, Precision BioSciences' Return On Equity is quite stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Precision BioSciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Precision BioSciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Precision BioSciences' earnings, one of the primary drivers of an investment's value.Precision Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Precision BioSciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Precision BioSciences could also be used in its relative valuation, which is a method of valuing Precision BioSciences by comparing valuation metrics of similar companies.Precision BioSciences is currently under evaluation in operating margin category among related companies.
Precision Fundamentals
| Return On Equity | -1.07 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (1.26) % | ||||
| Operating Margin | (2.12) % | ||||
| Current Valuation | (14.66 M) | ||||
| Shares Outstanding | 6.92 M | ||||
| Shares Owned By Insiders | 8.47 % | ||||
| Shares Owned By Institutions | 39.80 % | ||||
| Number Of Shares Shorted | 288.87 K | ||||
| Price To Earning | (6.10) X | ||||
| Price To Book | 5.18 X | ||||
| Price To Sales | 2.00 X | ||||
| Revenue | 48.73 M | ||||
| Gross Profit | 25.1 M | ||||
| EBITDA | (35.48 M) | ||||
| Net Income | (42.53 M) | ||||
| Cash And Equivalents | 184.14 M | ||||
| Cash Per Share | 1.66 X | ||||
| Total Debt | 31.27 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 4.59 X | ||||
| Book Value Per Share | 4.53 X | ||||
| Cash Flow From Operations | (84.11 M) | ||||
| Short Ratio | 1.31 X | ||||
| Earnings Per Share | (332.12) X | ||||
| Target Price | 35.8 | ||||
| Number Of Employees | 109 | ||||
| Beta | 1.57 | ||||
| Market Capitalization | 70.75 M | ||||
| Total Asset | 159.78 M | ||||
| Retained Earnings | (489.63 M) | ||||
| Working Capital | 86.37 M | ||||
| Current Asset | 174.05 M | ||||
| Current Liabilities | 23.86 M | ||||
| Net Asset | 159.78 M |
About Precision BioSciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Precision BioSciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precision BioSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precision BioSciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 12 M | 22.1 M | |
| Total Revenue | 48.7 M | 35.8 M | |
| Cost Of Revenue | 8.3 M | 8.7 M | |
| Stock Based Compensation To Revenue | 0.29 | 0.28 | |
| Sales General And Administrative To Revenue | 0.80 | 1.25 | |
| Research And Ddevelopement To Revenue | 1.01 | 0.96 | |
| Capex To Revenue | (0.05) | (0.05) | |
| Revenue Per Share | 12.68 | 12.64 | |
| Ebit Per Revenue | (0.90) | (0.94) |
Pair Trading with Precision BioSciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precision BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Precision BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precision BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precision BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precision BioSciences to buy it.
The correlation of Precision BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precision BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precision BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precision BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Precision BioSciences Piotroski F Score and Precision BioSciences Altman Z Score analysis. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (332.12) | Revenue Per Share 12.685 | Quarterly Revenue Growth (0.34) | Return On Assets (0.14) | Return On Equity (1.07) |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.